HomeAI · summaries
Storia in 9 fonti
Encouraging trial results for AstraZeneca's new weight-loss pill
A new pill developed by the British pharma firm AstraZeneca appears to help people lose a similar amount of weight to other GLP-1 oral drugs, trial results showed Monday.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.
- ·
endpoints.news
AstraZeneca's obesity pill matches rivals in Phase 2, anchoring $5B franchise push
AstraZeneca's oral GLP-1 elecoglipron cut weight up to 10.5% in Phase 2, as AZ launches multiple Phase 3 trials targeting a $5B obesity franchise.
